Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and Bayesian network analysis
Xingyu Xiong, Shiyu Zhang, Weitao Zheng, Xinyang Liao, Jie Yang, Hang Xu, Siping Hu, Qiang Wei, Lu Yang, Lu Yang
Topics & Concepts
MedicineProstate cancerOncologyEnzalutamideDocetaxelInternal medicineBiomarkerAbiraterone acetateCabazitaxelSystematic reviewAndrogen receptorAndrogen deprivation therapyCancerMEDLINELawBiochemistryPolitical scienceChemistryProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications